Autacoids as modulators of the inflammatory and immune response

The American Journal of Medicine
K L MelmonR P Rosenkranz

Abstract

Once considered only mediators of inflammation, autacoids, (histamine, prostaglandins and beta-mimetic catecholamines) have been found to be generated during specific early and late phases of immunity. They need sufficient concentrations to affect immunocytes and can modulate immunity usually by inhibiting it. Receptors for the autacoids on the immunocytes are nonrandomly distributed. A small portion of T suppressor cells always appear to have receptors on them, but precursor B cells and precursors of T cells that produce lymphokines or are responsible for cytolysis do not. Instead, as these cells mature they develop their autacoid receptors. With one exception, the function of the immunocytes is inhibited by the effects of autacoids. Again, in all but one instance, that inhibitory modulating effect is mediated by and directly proportional to the intracellular concentrations of cyclic adenosine monophosphate (AMP) generated by the autacoid. The clinical implications of these observations are beginning to be appreciated. One of them is that pharmacologic antagonists of the autacoids can have predictable but hitherto unanticipated effects on immune functions. It is inconceivable that these effects will not have clinical value.

References

Jan 1, 1976·Immunological Communications·Y Weinstein, K L Melmon
Feb 18, 1977·Science·W RoszkowskiL M Lichtenstein
Nov 1, 1975·The Journal of Allergy and Clinical Immunology·J A KramK L Melmon
Apr 5, 1974·Science·H R BourneG M Shearer
Jan 1, 1974·The Journal of Clinical Investigation·K L MelmonS Bauminger
Jan 1, 1974·The Journal of Clinical Investigation·K L MelmonS Bauminger
Jun 1, 1980·Immunopharmacology·A SchwartzR K Gershon
Jan 1, 1980·European Journal of Immunology·L A HerzenbergL A Herzenberg
May 29, 1980·The New England Journal of Medicine·R E RocklinK L Melmon
Jul 3, 1980·The New England Journal of Medicine·G WeissmannH M Korchak
Apr 1, 1980·Cell·E L Reinherz, S F Schlossman

❮ Previous
Next ❯

Citations

Sep 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·N A KlimenkoE D Gol'dberg
Apr 1, 1984·The Journal of Allergy and Clinical Immunology·D J Beer, R E Rocklin
Jan 1, 1990·Veterinary Immunology and Immunopathology·S L DanielP J Felsburg
Sep 1, 1994·International Journal of Immunopharmacology·N GorenE Borda
Jan 1, 1983·General Pharmacology·F MarceauJ P Giroud
Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J N SiegelR K Gershon
Feb 1, 1990·British Journal of Clinical Pharmacology·J R SnymanH S Schoeman
Jun 6, 1998·American Journal of Respiratory Cell and Molecular Biology·F H KrouwelsT A Out
Nov 6, 2009·Acta Paediatrica·H M Feder, J C Salazar
Mar 31, 2016·Autonomic & Autacoid Pharmacology·J M Keppel Hesselink
Jan 1, 1991·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·N NavehC Weissman
Apr 1, 1985·International Journal of Dermatology·J L JorizzoK M Fagan
Nov 1, 1985·Journal of Endodontics·M TorabinejadI J Naidorf
May 1, 1985·Experimental Eye Research·L N Fleisher, M C McGahan
May 7, 2003·The Annals of Otology, Rhinology, and Laryngology·Marco BerlucchiPiero Nicolai
Jun 21, 2017·Pain and Therapy·Jan M Keppel Hesselink
Apr 11, 2012·Pharmacoepidemiology and Drug Safety·Judith K JonesJames D Lewis
Oct 11, 2019·Current Opinion in Nephrology and Hypertension·Ross DoyleEoin Brennan
May 1, 1985·Seminars in Arthritis and Rheumatism·T L Moore, T D Weiss
Aug 1, 1984·Kidney International·J R Sedor, H E Abboud
Jul 1, 1991·Journal of the American Academy of Dermatology·L B Schwartz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.